MENU
+Compare
PHGUF
Stock ticker: OTC
AS OF
Dec 17 closing price
Price
$0.84
Change
+$0.08 (+10.53%)
Capitalization
607.8M

PHGUF Pharming Group NV Forecast, Technical & Fundamental Analysis

Industry Biotechnology
PHGUF
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
A.I.Advisor
a Summary for PHGUF with price predictions
Dec 18, 2024

Momentum Indicator for PHGUF turns positive, indicating new upward trend

PHGUF saw its Momentum Indicator move above the 0 level on December 09, 2024. This is an indication that the stock could be shifting in to a new upward move. Traders may want to consider buying the stock or buying call options. Tickeron's A.I.dvisor looked at 67 similar instances where the indicator turned positive. In of the 67 cases, the stock moved higher in the following days. The odds of a move higher are at .

Price Prediction Chart

Technical Analysis (Indicators)

Bullish Trend Analysis

The Moving Average Convergence Divergence (MACD) for PHGUF just turned positive on December 11, 2024. Looking at past instances where PHGUF's MACD turned positive, the stock continued to rise in of 44 cases over the following month. The odds of a continued upward trend are .

PHGUF moved above its 50-day moving average on December 17, 2024 date and that indicates a change from a downward trend to an upward trend.

Bearish Trend Analysis

The RSI Indicator has been in the overbought zone for 1 day. Expect a price pull-back in the near future.

The Stochastic Oscillator demonstrated that the ticker has stayed in the overbought zone for 7 days. The longer the ticker stays in the overbought zone, the sooner a price pull-back is expected.

The 10-day moving average for PHGUF crossed bearishly below the 50-day moving average on November 27, 2024. This indicates that the trend has shifted lower and could be considered a sell signal. In of 13 past instances when the 10-day crossed below the 50-day, the stock continued to move higher over the following month. The odds of a continued downward trend are .

Following a 3-day decline, the stock is projected to fall further. Considering past instances where PHGUF declined for three days, the price rose further in of 62 cases within the following month. The odds of a continued downward trend are .

PHGUF broke above its upper Bollinger Band on December 17, 2024. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options.

The Aroon Indicator for PHGUF entered a downward trend on November 20, 2024. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.

Fundamental Analysis (Ratings)

The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to outstanding earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating steady price growth. PHGUF’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron Valuation Rating of (best 1 - 100 worst) indicates that the company is slightly overvalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (2.535) is normal, around the industry mean (14.294). P/E Ratio (0.000) is within average values for comparable stocks, (87.370). Projected Growth (PEG Ratio) (0.000) is also within normal values, averaging (1.766). PHGUF has a moderately low Dividend Yield (0.000) as compared to the industry average of (0.012). P/S Ratio (2.128) is also within normal values, averaging (256.769).

The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating slightly better than average sales and a considerably profitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating that the returns do not compensate for the risks. PHGUF’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 94, placing this stock worse than average.

View a ticker or compare two or three
PHGUF
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Ad is loading...
A.I. Advisor
published General Information

General Information

Industry Biotechnology

Profile
Fundamentals
Details
Industry
N/A
Address
Darwinweg 24
Phone
+31 715247400
Employees
332
Web
https://www.pharming.com
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
SMTOY18.17-0.16
-0.86%
Sumitomo Electric Industries Ltd.
AOIFF1.27-0.02
-1.55%
Africa Oil Corp.
TTDKY13.00-0.28
-2.11%
TDK Corp.
FRCOY33.48-1.16
-3.35%
Fast Retailing Co. Ltd.
MWSNF0.66-0.04
-5.04%
Mawson Gold Ltd.

PHGUF and Stocks

Correlation & Price change

A.I.dvisor tells us that PHGUF and DRUG have been poorly correlated (+28% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that PHGUF and DRUG's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To PHGUF
1D Price
Change %
PHGUF100%
N/A
DRUG - PHGUF
28%
Poorly correlated
-4.33%
CGTX - PHGUF
25%
Poorly correlated
+27.50%
IMMP - PHGUF
23%
Poorly correlated
+1.88%
XFOR - PHGUF
23%
Poorly correlated
-13.21%
TVGN - PHGUF
22%
Poorly correlated
-10.40%
More